Noncoding RNAs in cancer ferroptosis: From biology to clinical opportunity

• Published in: Biomedicine & pharmacotherapy 2023-09, Vol.165, p.115053-115053, Article 115053
• Main Authors: Shan, Chan, Liang, Yan, Wang, Kun, Li, Peifeng
• Format: Article
• Language: English
• Subjects: Cancer therapy; Cell death; Ferroptosis; Noncoding RNA; Regulatory mechanism
• ISSN: 0753-3322; 1950-6007
• DOI: 10.1016/j.biopha.2023.115053

Ferroptosis is a recently discovered pattern of programmed cell death that is nonapoptotic and irondependent. It is involved in lipid peroxidation dependent on reactive oxygen species. Ferroptosis has been verified to play a crucial regulatory role in a variety of pathological courses of disease, in particularly cancer. Emerging research has highlighted the potential of ferroptosis in tumorigenesis, cancer development and resistance to chemotherapy. However, the regulatory mechanism of ferroptosis remains unclear, which limits the application of ferroptosis in cancer treatment. Noncoding RNAs (ncRNAs) are noncoding transcripts that regulate gene expression in various ways to affect the malignant phenotypes of cancer cells. At present, the biological function and underlying regulatory mechanism of ncRNAs in cancer ferroptosis have been partially elucidated. Herein, we summarize the current knowledge of the central regulatory network of ferroptosis, with a focus on the regulatory functions of ncRNAs in cancer ferroptosis. The clinical application and prospects of ferroptosis-related ncRNAs in cancer diagnosis, prognosis and anticancer therapies are also discussed. Elucidating the function and mechanism of ncRNAs in ferroptosis, along with assessing the clinical significance of ferroptosis-related ncRNAs, provides new perspectives for understanding cancer biology and treatment approaches, which may benefit numerous cancer patients in the future. [Display omitted] •Ferroptosis is a novel mode of programmed cell death that participates in cancer progress and response to therapies.•Dysregulated noncoding RNAs contribute to cancer management by targeting ferroptosis.•Ferroptosis-related noncoding RNAs perform significant potential as biomarkers and therapeutic targets for cancer.